The DOI matches its Crossref record; 216 of the 216 references it cites were found in a registry or an index.
Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus
Abstract
This work provides a systematic review of the literature from January 2003 to April 2014 pertaining to the incidence, pathophysiology, diagnosis, and treatment of osteonecrosis of the jaw (ONJ), and offers recommendations for its management based on multidisciplinary international consensus. ONJ is associated with oncology-dose parenteral antiresorptive therapy of bisphosphonates (BP) and denosumab (Dmab). The incidence of ONJ is greatest in the oncology patient population (1% to 15%), where high doses of these medications are used at frequent intervals. In the osteoporosis patient population, the incidence of ONJ is estimated at 0.001% to 0.01%, marginally higher than the incidence in the general population (<0.001%). New insights into the pathophysiology of ONJ include antiresorptive effects of BPs and Dmab, effects of BPs on gamma delta T-cells and on monocyte and macrophage function, as well as the role of local bacterial infection, inflammation, and necrosis. Advances in imaging include the use of cone beam computerized tomography assessing cortical and cancellous architecture with lower radiation exposure, magnetic resonance imaging, bone scanning, and positron emission tomography, although plain films often suffice. Other risk factors for ONJ include glucocorticoid use, maxillary or mandibular bone surgery, poor oral hygiene, chronic inflammation, diabetes mellitus, ill-fitting dentures, as well as other drugs, including antiangiogenic agents. Prevention strategies for ONJ include elimination or stabilization of oral disease prior to initiation of antiresorptive agents, as well as maintenance of good oral hygiene. In those patients at high risk for the development of ONJ, including cancer patients receiving high-dose BP or Dmab therapy, consideration should be given to withholding antiresorptive therapy following extensive oral surgery until the surgical site heals with mature mucosal coverage. Management of ONJ is based on the stage of the disease, size of the lesions, and the presence of contributing drug therapy and comorbidity. Conservative therapy includes topical antibiotic oral rinses and systemic antibiotic therapy. Localized surgical debridement is indicated in advanced nonresponsive disease and has been successful. Early data have suggested enhanced osseous wound healing with teriparatide in those without contraindications for its use. Experimental therapy includes bone marrow stem cell intralesional transplantation, low-level laser therapy, local platelet-derived growth factor application, hyperbaric oxygen, and tissue grafting. © 2014 American Society for Bone and Mineral Research © 2014 American Society for Bone and Mineral Research
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–216 of 216
Salzman, R., Hoza, J., Peřina, V., & Stárek, I. (2013) · Otology & Neurotology · doi:10.1097/mao.0b013e31827ca34d · Cited by 32
Advances in Treating Metastatic Bone Cancer: Summary Statement for the First Cambridge Conference
Lipton, A., Berenson, J. R., Body, J.-J., Boyce, B. F., Bruland, Ø. S., Carducci, M. A., Cleeland, C. S., Clohisy, D. R., Coleman, R. E., Cook, R. J., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1213 · Cited by 31
Self-citationZoledronic Acid Treatment at Home: Safety Data from an Observational Prospective Trial
Tassinari, D., Poggi, B., Nicoletti, S., Fantini, M., Tamburini, E., Possenti, C., & Sartori, S. (2007) · Journal of Palliative Medicine · doi:10.1089/jpm.2006.0122 · Cited by 26
Safra, T., Bernstein‐Molho, R., Greenberg, J., Pelles-Avraham, S., Stephansky, I., Sarid, D. L., Inbar, M., Stemmer, S. M., & Geffen, D. B. (2011) · Oncology · doi:10.1159/000334456 · Cited by 26
Iwamoto, J., Kaori, Y. A. G. O., Satō, Y., & Matsumoto, H. (2012) · Clinical Drug Investigation · doi:10.1007/bf03261908 · Cited by 24
Capalbo, S. F., Delia, M., Diomede, D., Dargenio, M., Chiefa, A., Favia, G., & Liso, V. (2006) · International Journal of Hematology · doi:10.1532/ijh97.e0536 · Cited by 20
Berenson, J. R., Yellin, O., Crowley, J. J., Makary, A. Z., Gravenor, D. S., Yang, H. H., Upadhyaya, G. H., Flinn, I. W., Staszewski, H., Tiffany, N. M., et al. (2010) · American Journal of Hematology · doi:10.1002/ajh.21912 · Cited by 19
Morris, P. G., Fazio, M., Farooki, A., Estilo, C. L., Mallam, D., Conlin, A. K., Patil, S. N., Fleisher, M., Cremers, S., Huryn, J. M., et al. (2012) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2011.12.028 · Cited by 19
Fortuna, G., Ruoppo, E., Pollio, A., Aria, M., Adamo, D., Leuci, S., Orabona, G. D., & Mignogna, M. D. (2011) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2011.01095.x · Cited by 19
Role of magnetic resonance imaging in diagnosis of bisphosphonate-related osteonecrosis of the jaw
Ariji, Y., & Ariji, E. (2013) · Oral Radiology · doi:10.1007/s11282-013-0124-6 · Cited by 16
Fatterpekar, G. M., Emmrich, J., Eloy, J. A., & Aggarwal, A. (2011) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0b013e318227a81d · Cited by 16
Allen, M. R., Pandya, B., & Ruggiero, S. L. (2010) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2010.05.090 · Cited by 14
Self-citationFitzpatrick, S. G., Stavropoulos, M. F., Bowers, L. M., Neuman, A. N., Hinkson, D. W., Green, J. G., Bhattacharyya, I., & Cohen, D. M. (2011) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2011.02.049 · Cited by 13
Young, J. R., Nickman, N. A., BISKUPIAK, J. E., Barney, R. B., Gaffney, D. K., Namjoshi, M. A., & Brandt, P. S. (2012) · The Breast · doi:10.1016/j.breast.2012.09.012 · Cited by 7
Sambrook, P. N., Roux, C., Devogelaer, J.-P., Saag, K., Lau, C.-S., Reginster, J.-Y., Bucci-Rechtweg, C., Su, G., & Reid, D. M. (2012) · Bone · doi:10.1016/j.bone.2011.10.024 · Cited by 3
Cited by
Compston, J. E., McClung, M. R., & Leslie, W. D. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32112-3 · Cited by 2,449
Self-citationBlack, D. M., & Rosen, C. J. (2016) · New England Journal of Medicine · doi:10.1056/nejmcp1513724 · Cited by 1,712
The clinician's guide to prevention and treatment of osteoporosis
LeBoff, M. S., Greenspan, S. L., Insogna, K. L., Lewiecki, E. M., Saag, K. G., Singer, A. J., & Siris, E. S. (2022) · Osteoporosis International · doi:10.1007/s00198-021-05900-y · Cited by 1,487
Camacho, P. M., Petak, S. M., Binkley, N., Diab, D. L., Eldeiry, L. S., Farooki, A., Harris, S. T., Hurley, D. L., Kelly, J., Lewiecki, E. M., et al. (2020) · Endocrine Practice · doi:10.4158/gl-2020-0524suppl · Cited by 1,182
Self-citationRuggiero, S. L., Dodson, T. B., Aghaloo, T., Carlson, E. R., Ward, B. B., & Kademani, D. (2022) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2022.02.008 · Cited by 1,141
Self-citation
Metadata
- Authors
- Khan, A. A., Morrison, A., Hanley, D. A., Felsenberg, D., McCauley, L. K., O'Ryan, F., Reid, I. R., Ruggiero, S. L., Taguchi, A., Tetradis, S., Watts, N. B., Brandi, M. L., Peters, E., Guise, T., Eastell, R., Cheung, A. M., Morin, S. N., Masri, B., Cooper, C., Morgan, S. L., Obermayer-Pietsch, B., Langdahl, B. L., Al Dabagh, R., Davison, K. S., Kendler, D. L., Sándor, G. K., Josse, R. G., Bhandari, M., El Rabbany, M., Pierroz, D. D., Sulimani, R., Saunders, D. P., Brown, J. P., Compston, J., & on behalf of the International Task Force on Osteonecrosis of the Jaw
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-11-21
- Volume
- 30
- Issue
- 1
- Pages
- 3-23
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W1957467225
- Cited by
- 1,353
- References
- 216
- FWCI
- 8.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.